Bonnita Werner
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer.
Journal: Molecular oncology
Published: March 26, 2024
Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trial.
Journal: Translational oncology
Published: July 10, 2023
Transcending Blood-Opportunities for Alternate Liquid Biopsies in Oncology.
Journal: Cancers
Published: February 08, 2022
Circulating cell-free DNA undergoes significant decline in yield after prolonged storage time in both plasma and purified form.
Journal: Clinical chemistry and laboratory medicine
Published: October 28, 2021
Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer.
Journal: Gynecologic oncology
Published: February 02, 2021
The untapped potential of ascites in ovarian cancer research and treatment.
Journal: British journal of cancer
Published: September 20, 2019
Circulating cell-free DNA from plasma undergoes less fragmentation during bisulfite treatment than genomic DNA due to low molecular weight.
Journal: PloS one
Published: July 18, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026